SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073751
Filing Date
2024-06-14
Accepted
2024-06-14 16:40:23
Documents
2
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3922
2 EX-24.POA trvi-ex24_poa.htm EX-24.POA 27636
  Complete submission text file 0000950170-24-073751.txt   33013
Mailing Address C/O MEDIMMUNE, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 241045481

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)